Estimating the cost-effectiveness of stroke units in France compared with conventional care

被引:71
作者
Launois, R
Giroud, M
Mégnigbêto, AV
Le Lay, K
Présenté, G
Mahagne, MH
Durand, I
Gaudin, AF
机构
[1] Univ Paris 13, Paris, France
[2] Reseau Evaluat Econ Sante, Paris, France
[3] CHU, Serv Neurol, Dijon, France
[4] CHU Nice, Nice, France
[5] Lab GlaxoSmithKline, MArly Le Roi, France
关键词
cost-benefit analysis; economics; Markov chains; stroke; stroke units;
D O I
10.1161/01.STR.0000117574.19517.80
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-The incidence of stroke in France is estimated at between 120000 and 150000 cases per year. This modeling study assessed the clinical and economic benefits of establishing specialized stroke units compared with conventional care. Methods-Data from the Dijon stroke registry were used to determine healthcare trajectories according to the degree of autonomy and organization of patient care. The relative risks of death or institutionalization or death or dependence after passage through a stroke unit were compared with conventional care. These risks were then inserted with the costing data into a Markov model to estimate the cost-effectiveness of stroke units. Results-Patients cared for in a stroke unit survive more trimesters without sequelae in the 5 years after hospitalization than those cared for conventionally (11.6 versus 8.28 trimesters). The mean cost per patient at 5 years was estimated at 30 983 C for conventional care and 34638 C in a stroke unit. An incremental cost-effectiveness ratio for stroke units of 1359 C per year of life gained without disability was estimated. Conclusions-The cost-effectiveness ratio for stroke units is much lower than the threshold (53400 C) of acceptability recognized by the international scientific community. This finding justifies organizational changes in the management of stroke patients and the establishment of stroke units in France.
引用
收藏
页码:770 / 775
页数:6
相关论文
共 21 条
[1]   Stroke management in Europe [J].
Aboderin, I ;
Venables, G .
JOURNAL OF INTERNAL MEDICINE, 1996, 240 (04) :173-180
[2]  
BEAUMEL C, 1999, 7576 INSEE DEM SOC
[3]   A CONVENIENT APPROXIMATION OF LIFE EXPECTANCY (THE DEALE) .2. USE IN MEDICAL DECISION-MAKING [J].
BECK, JR ;
PAUKER, SG ;
GOTTLIEB, JE ;
KLEIN, K ;
KASSIRER, JP .
AMERICAN JOURNAL OF MEDICINE, 1982, 73 (06) :889-897
[4]  
BOUGET D, 1991, ECONOMICA PARIS, P254
[5]   LONG-TERM RISK OF RECURRENT STROKE AFTER A FIRST-EVER STROKE - THE OXFORDSHIRE COMMUNITY STROKE PROJECT [J].
BURN, J ;
DENNIS, M ;
BAMFORD, J ;
SANDERCOCK, P ;
WADE, D ;
WARLOW, C .
STROKE, 1994, 25 (02) :333-337
[6]   LONG-TERM SURVIVAL AFTER 1ST-EVER STROKE - THE OXFORDSHIRE COMMUNITY STROKE PROJECT [J].
DENNIS, MS ;
BURN, JPS ;
SANDERCOCK, PAG ;
BAMFORD, JM ;
WADE, DT ;
WARLOW, CP .
STROKE, 1993, 24 (06) :796-800
[7]  
*ENQ PREMUTAM, 1992, 1987 1991 APP MAINT, V2
[8]  
*ENQ PREMUTAM, 1992, 1987 1991 APP MAINT, V1
[9]   INCIDENCE AND SURVIVAL RATES DURING A 2-YEAR PERIOD OF INTRACEREBRAL AND SUBARACHNOID HEMORRHAGES, CORTICAL INFARCTS, LACUNES AND TRANSIENT ISCHEMIC ATTACKS - THE STROKE-REGISTRY-OF-DIJON - 1985-1989 [J].
GIROUD, M ;
MILAN, C ;
BEURIAT, P ;
GRAS, P ;
ESSAYAGH, E ;
ARVEUX, P ;
DUMAS, R .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1991, 20 (04) :892-899
[10]   Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations [J].
Hankey, GJ ;
Warlow, CI .
LANCET, 1999, 354 (9188) :1457-1463